Drugs / CSL Limited Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00562484 | Mar 2008 → Nov 2009 | influenza | Seqirus | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSL Limited Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00562484 ↗ |
| Modality | Vaccine | “seasonal trivalent inactivated influenza vaccines (IIV3s)” PMID 27595443 ↗ Aug 2016 |
| Route | Intramuscular | “administered intramuscularly” NCT00562484 ↗ |